|
AI is reshaping healthcare fast. Below are 3 key AI developments, 2 studies, and 1 takeaway to help you better lead with AI. Target read time: 5 minutes.
|
The FDA announced it will relax regulation of clinical decision support software, allowing AI tools that help doctors with diagnoses and treatment options to launch without FDA review if they meet other criteria. Commissioner Marty Makary said the agency needs to move "at Silicon Valley speed." High-risk products that diagnose or treat disease remain regulated.
So what?
For AI vendors, faster time to market. For health systems, less regulatory cover—and more responsibility to vet the tools they deploy.
Read the guidance →
OpenAI introduced a dedicated health chatbot that integrates with patient portals and wellness apps like Apple Health and MyFitnessPal. Users can review test results, prep for appointments, and compare insurance plans. Privacy safeguards include purpose-built encryption and data stored separately from other ChatGPT conversations. The fine print: "not designed for diagnosis or treatment."
So what?
The first foundation model company to build a dedicated health product. Google, Meta, and Anthropic are likely watching closely—and not far behind.
Read the full story →
New regulations took effect January 1 in California, Texas, Indiana, Kentucky, and Rhode Island. Texas (TRAIGA) requires written disclosure of AI use in diagnosis or treatment, with penalties up to $200K per violation. California (AB 489) bans AI from implying it holds a healthcare license and requires companion chatbots to provide crisis referrals, while AB 2013 mandates developers disclose training data information. Indiana, Kentucky, and Rhode Island granted consumers the right to opt out of AI-driven profiling.
Read the full story →
|
40 million weekly active users prompt ChatGPT daily about their health. 70% of these health conversations happen outside clinic hours. Of that, 1.6-1.9 million weekly queries focus on health insurance—plan selection, billing, claims. In underserved rural communities, users send nearly 600,000 healthcare-related messages every week. In contrast, <20% of health organizations report using AI at scale.
Why it matters
Consumer AI adoption isn't waiting for the healthcare industry.
Read the report →
Survey of 501 physicians found: 60% use it to look up clinical info, 55% to integrate lab/imaging results, 56% to surface clinical evidence. But 50% say fragmented or outdated data limits AI usefulness. Only 2% report no data access challenges.
Why it matters
Despite data fragmentation and access challenges, early adopter physicians are expanding the use cases for AI.
Read the survey →
|
The consumer isn't waiting for our health system.
Already, 40 million people ask ChatGPT health questions every day—more than the daily patient volume of every urgent care center in America combined. OpenAI's January report positions AI alongside primary care, urgent care, and telehealth as a "first stop for medical information."
The usage patterns are telling: 70% of health conversations happen outside clinic hours, when providers are unavailable. 1.6-1.9 million weekly messages focus on insurance—plan comparisons, billing disputes, coverage questions. Consumers are routing around the call center.
Then this week came ChatGPT Health, and OpenAI became the first foundation model company to launch a dedicated health product—integrating patient portals, wellness apps, and medical records into a single interface. The disclaimers are broad ("not designed for diagnosis or treatment"), but that's not stopping people.
Takeaway
Payers and providers have spent years debating AI governance. Meanwhile, 200 million people a week are already using ChatGPT for health. The consumer didn't wait for permission. The question now isn't whether to engage with direct-to-consumer AI—it's how to avoid being disintermediated by it.
|
|